Psychotherapy for Personality Disorder
Anthony W. Bateman
Peter Fonagy
Introduction
Psychotherapy has historically been the mainstay of treatment for personality disorder (PD). It remains so. Psychoanalysis was probably the earliest formal treatment for PD, which led to the first clinical descriptions of borderline personality disorder. A parallel but linked development was the application of psychoanalytic ideas in therapeutic communities which have been in existence for over 60 years and remain a treatment context and method for patients with PD. It was only in the 1960s that modified psychotherapeutic treatments were developed. Initially these were based on psychodynamic understanding of PD, but gradually other theoretically and practically driven models have developed, leading to the current situation in which there are behavioural, cognitive, dynamic, and supportive treatments offered in a range of contexts. Some of these methods have more empirical support than others. These methods will be described in this chapter.
Psychological therapies for personality disorders take place against the background of the natural course and outcome of the disorder. Until recently, the natural history of personality disorder had not been systematically studied. Several major cohort follow-along studies have yielded surprising data concerning the rate of symptomatic remissions in a disorder that was assumed to have a lifelong course.(1) For example, over a 10-year follow-along period, 88 per cent of those initially diagnosed with borderline personality disorder appeared to remit in the sense of no longer meeting DIB-R or DSM-III criteria for BPD for 2 years.(2) The symptoms that remit most readily, irrespective of treatment, appear to be the acute ones, such as parasuicide and self-injury, which are the most likely to trigger psychotherapeutic intervention. Temperamental symptoms, such as angry feelings and acts, distrust and suspicion, abandonment concerns, and emotional instability, appear to resolve far more slowly. In the Collaborative Longitudinal Personality Disorder Study (CLPS),(3) when remission was defined as 12 months at two or fewer criteria for PDs, over half of BPD and 85 per cent of major depressive disorder (MDD) patients were reported to remit over a 4-year period. Psychosocial functioning recovered far more slowly than acute symptoms.(1)
There is a considerable body of literature on psychotherapeutic interventions for personality disorders, but significant evidence
for effective treatment remains sparse. Much of the literature is dominated by expert opinion, which is not invariably the most helpful guide. In this chapter, we focus on psychological treatments where at least some evidence for treatment effectiveness exists. The evidence is strongest for borderline personality disorder (BPD). Treatment of some other personality disorders, for example schizoid, narcissistic, obsessive-compulsive, dependent, is evidenced mainly by clinical case reports in which theory is combined with clinical description and where, if outcome is measured at all, it is measured for the purpose of illustration and has little probative value.
for effective treatment remains sparse. Much of the literature is dominated by expert opinion, which is not invariably the most helpful guide. In this chapter, we focus on psychological treatments where at least some evidence for treatment effectiveness exists. The evidence is strongest for borderline personality disorder (BPD). Treatment of some other personality disorders, for example schizoid, narcissistic, obsessive-compulsive, dependent, is evidenced mainly by clinical case reports in which theory is combined with clinical description and where, if outcome is measured at all, it is measured for the purpose of illustration and has little probative value.
Assessment of treatment
Any study that seeks to demonstrate the effectiveness of a treatment for PD must fulfil the following requirements:
Carefully define the target population. This can be problematic, because the definition of personality disorder (PD) remains controversial, and there is little evidence that the categories of personality disorder have any predictive value in determining response to treatment. Comorbidity must also be considered. Lifetime comorbidity should not be an exclusion criterion for studies, but there is an argument for excluding individuals with current comorbidity. However, in clinical practice, such exclusion is almost impossible.
Adequately define the treatment and assessment of its specificity. Personality disorder is a multifaceted condition that is susceptible to a variety of influences, and it justifies the use of complex interventions. These require complex evaluations, which increase the difficulty of interpreting results.
Establish that treatment is superior to no treatment since personality disorders show gradual improvement over time.
Take account of Axis I disorders. This can be done by excluding patients with Axis I disorders, but PDs are almost always associated with significant Axis I psychopathology. An alternative, which no trial has, to date, attempted, would be to assign patients to treatment group on the basis of matched Axis I disorders. In any case, it must be demonstrated that treatment impacts on personality rather than merely causing a change in mood or psychiatric symptoms.
Include adequate follow-up, as some trials report reduced treatment effects during follow-up.
Address cost-effectiveness relative to alternative interventions.
Study treatment effects in standard practice (pragmatic trials) as well as under strict experimental conditions.
Research trials investigating the effectiveness of treatments for personality disorder have so far singularly failed to meet most of these requirements.
Adverse effects of psychotherapy for personality disorder
It is possible that some psychosocial treatments for personality disorder may have impeded the patient’s capacity to recover following the natural course of the disorder and/or prevented them from taking advantage of changes in social circumstances. In Stone’s(4) classic follow-up of patients treated nearly 40 years ago, a 66 per cent recovery rate was only achieved in 20 years, about four times longer than reported in the more recent studies. It seems unlikely that the nature of the disorder has changed or that treatments have become markedly more effective rather it is possible that treatments with these adverse effects are being offered less frequently now than in the past, perhaps because of changed patterns of health care, particularly in the United States.
Meta-analyses of psychotherapy and psychosocial treatments
It remains unclear whether the literature is robust enough to withstand the methodology of meta-analysis. The lack of good quality studies, especially randomized trials, the small number of patients in the trials, the heterogeneity of the personality disorders studied, and the variability of outcome measures across studies means that conclusions must remain tentative. One meta-analysis(5) included 15 studies that reported data on pre- to post-treatment effects and/or recovery at follow-up, including three randomized, controlled trials, three randomized comparisons of active treatments, and nine uncontrolled observational studies. They included psychodynamic/interpersonal, cognitive behavioural, mixed, and supportive therapies. All studies reported improvement in personality disorders with treatment. The mean pre-post effect sizes within treatments were 1.11 for self-report measures and 1.29 for observational measures. Among the three randomized, controlled treatment trials, active psychotherapy was more effective than no treatment according to self-report (ES = 0.75), though none of the controls employed an active therapy. Only four studies reported the percentage of cases no longer meeting the criteria for personality disorder. At follow-up (at a mean of 67 weeks), 52 per cent met this criterion. Treatment length was associated with the likelihood of recovery.
A subsequent meta-analysis(6) included psychodynamic therapy and cognitive behaviour therapy (CBT) in the treatment of personality disorders. There were 22 studies of psychodynamic therapy and CBT published between 1974 and 2001 that (1) used standardized methods of diagnosis, (2) applied reliable and valid instruments for the assessment of outcome, and (3) reported data that allowed calculation of within-group effect sizes or included assessment of recovery rates. Because only 11 of the 22 studies were RCTs, ESs were calculated on the basis of pre- to post-therapy change. Fourteen studies included psychodynamic therapy, and 11 studies included CBT. The psychodynamic studies had a mean follow-up of 1.5 years, compared to only 13 weeks for CBT. Psychodynamic therapy yielded an overall effect size of 1.46 (k = 15 contrasts), with effect sizes of 1.08 for self-report measures and 1.79 for observer-rated measures. For CBT (k = 10 contrasts), the corresponding values were 1.00, 1.20, and 0.87. For more specific measures of personality disorder pathology, a large overall effect size (1.56) for psychodynamic therapy suggested long-term rather than short-term change in personality disorders. For BPD, the ES for psychodynamic therapy was 1.31 (N = 8), and for CBT 0.95 (N = 4). Treatment length showed a positive but no°nsignificant correlation with outcome in psychodynamic studies (r = 0.41); there were too few CBT trials for an equivalent analysis. In the 5 years since 2001, there have been nearly as many new randomized trials of treatments for personality disorder as were included in this meta-analysis, so a further systematic review including only randomized trials is due.
Psychotherapy for borderline personality disorder (BPD)
Several psychosocial treatments for BPD have emerged over the past decade, with one US guideline recommending psychotherapy as the primary treatment for this condition.(7) It is impossible to recommend one specific therapy, because information from research remains inadequate. It has become clear not only that several treatments may be of use, but also that any one treatment by itself, is helpful in only about a half of all cases.(8) Also, there is general consensus that some of the nonspecific elements of psychotherapy may be as important in determining the success of a treatment as the specific techniques. We reviewed treatments shown to be moderately effective and concluded that they share certain common features.(9) They tend to (a) be well-structured, (b) devote considerable effort to enhancing collaboration, (c) have a clear focus, (d) be theoretically highly coherent to both therapist and patient, (e) be relatively long-term, (f) encourage a powerful attachment relationship between therapist and patient, and (g) be well integrated with other services available to the patient. While some of these features may seem to pertain more to a successful research study rather than a successful therapy, the manner in which clinical treatment protocols are constructed and delivered is probably as important in the success of treatment as the intervention itself.
(a) Dynamic psychotherapy
Dynamic psychotherapy has long been recommended for BPD and has now been modified to target the characteristic features of the disorder. Almost all of the first studies examined inpatient treatment using prospective one group pre- to post-test designs.(10) These studies failed to rule out other plausible causes of change, such as passage of time or subsequent outpatient treatment. Stone’s(11) report of up to 20 years follow-up of 550 inpatients, most of whom had received some sort of psychosocial intervention, indicated that 66 per cent of patients were functioning well. However, a naturalistic 5-year follow-up of individuals receiving inpatient treatment at the Cassel Hospital in London indicates the need for caution in ascribing benefits to inpatient treatment.(12) Whilst longer term follow-ups are to be applauded, they are hard to interpret, because other therapies are often given subsequent to the original treatment.
Several nonrandomized trials of dynamic psychotherapy have been undertaken by Stevenson, Meares, and colleagues. In an open trial for 48 patients receiving twice-weekly interpersonal-psychodynamic outpatient therapy for 12 months,(13) 30 per cent of the treatment group no longer met DSM-III-R criteria for BPD, while the waiting-list group changed little. Cost-benefit analysis found significant reduction in costs, largely attributable to reduced inpatient stays.
A replication study(14) also found significant reduction in symptom severity with the same treatment. A randomized study of 38 patients with BPD compared an 18-month programme of partial hospitalization using mentalizationbased treatment (MBT) with standard psychiatric care.(15) Mentalization entails making sense of the actions of oneself and others on the basis of intentional mental states such as desires, feelings, and beliefs. Outcome measures included frequency of suicide attempts, acts of self-harm, number and duration of inpatient admissions, use of psychotropic medication, and self-report measures including depression, interpersonal function, and social adjustment. After 6 months, patients given MBT showed a statistically significant decrease on all measures in contrast to the control group which showed limited change or deterioration over the same period. This was sustained at the end of the 18 months of treatment and showed further improvement on follow-up after another 18 months. Long-term follow-up 5 years after the initial treatment suggested that the differences between the groups continued, but general social function remained impaired in both groups.(16) The treatment was cost-effective and has been manualized,(17) but as yet the active components remain unclear, and it has not been shown that positive outcomes are correlated with an improvement in mentalizing. (An outpatient version of MBT is currently being evaluated for borderline and antisocial PD in a further randomized controlled trial.) Although promising, this treatment needs further validation by research carried out independently of the originators. Favourable data has recently become available on the effectiveness of a similar programme established in the Netherlands.(18)
Transference-focused psychotherapy (TFP) has also shown good results. In a cohort study,(19) 23 female borderline patients were treated for 12 months. Compared with the year before treatment, the number of patients who made suicide attempts decreased significantly, as did the medical risk and severity of self-injurious behaviour. Also, compared with the previous year, there were significantly fewer hospitalizations and fewer days of psychiatric hospitalization. However, one in five patients dropped out of treatment. A subsequent trial compared TFP, DBT, and supportive therapy.(20) Ninety patients (all but nine of whom were women) were randomized. At the end of 1 year of treatment, the groups did not differ on global assessment of functioning, social adjustment, scores of depression and anxiety, and measures of self-harm. TFP patients improved significantly more than those receiving DBT or supportive therapy on irritability and verbal and direct assault. Patients who received TFP improved most in reflective function, an operationalization of the mentalization construct,(21) but it is not known whether improved reflective function relates to treatment gains at follow-up.
Schema-focused therapy (SFT) has been compared with TFP.(22) Treatment was given by therapists with approved training in the treatment methods administered treatment to 88 patients with borderline personality disorder. In an ‘intent to treat’ analysis, patients who received TFP showed significantly less improvement than those who received schema-focused CBT over 3 years, and TFP was more expensive. Both groups showed improvement, but changes in the combined measure of outcome in the schema-focused therapy group were greater and more prolonged than in the TFP group. There are several reasons for caution regarding these conclusions. (i) Differences in outcome between the groups can be accounted for almost entirely by the larger dropout early in treatment of patients treated with TFP and disappear when ‘completers’ are compared. It would be valuable to know why more patients dropped out from TFP at an early stage than from SFT. (ii) Follow-up is required to determine whether treatment gains and group differences are maintained. (iii) In the duration of the treatment period, around 40 per cent of patients could be expected to improve without the treatment.(23) This study also raises the question of how successfully a treatment (TFP) from the US can be transported to a European context.
(b) Group psychotherapy
Noncontrolled studies of day hospital stabilization followed by outpatient dynamic group therapy indicate its utility for BPD.(24) Marziali and Monroe-Blum used group therapy focused on relationship management and without the milieu and social components. A randomized controlled trial found equivalent results between group and individual therapy, suggesting that group therapy is more cost-effective.(25) Further studies are needed to confirm their findings, especially since dropout rates were high.
(c) Cognitive analytical therapy (CAT)
CAT has been manualized for treatment of BPD, and many are enthusiastic about its effectiveness. There are some indications that it may be effective. In a series of 27 patients with borderline personality disorder treated with 24 sessions of CAT, half no longer met diagnostic criteria for personality disorder at 6-month followup.(26) More definitive statements about efficacy await results of a randomized trial in progress. Ryle (personal communication) has indicated that patients treated with CAT showed significant improvement on a range of clinical measures but reported no difference between people receiving CAT and those undergoing other psychological treatments. Thus, the effects may be nonspecific. A second randomized trial is in progress comparing CAT with ‘best available standard care’ for adolescent patients with borderline personality disorder.(27)
(d) Cognitive therapy
Cognitive behavioural formulations of BPD are diverse. In a model derived from ‘standard’ CBT and modified for personality disorders, Beck and associates(28) define personality in terms of patterns of social, motivational, and cognitive-affective processes, thereby moving away from a primary emphasis on cognitions. However, personality is considered to be determined by ‘idiosyncratic structures’, known as schemas, whose cognitive content gives meaning to the person, and these schemas are the cornerstone of cognitive formulations of BPD. Young(29) has developed a treatment programme for BPD based on early maladaptive schemas (EMS). These are stable, enduring patterns of thinking and perception that begin early in life and are continually elaborated. EMS are unconditional beliefs linked together to form the core of an individual’s self-image. Challenge to these beliefs threatens the core identity which is defended with alacrity, guile, and desperation since activation of the schemas may evoke aversive emotions. The EMS give rise to ‘schema coping behaviour’, which offers the best adaptation to living that the borderline has found. Schema-focused therapy (SFT) is only just being evaluated, but its adherence to the general requirements of an effective treatment enumerated above suggests that it should be reasonably successful. The recent report comparing SFT with TFP(22) is described above, but SFT has yet to be shown to be more effective than treatment as usual. It is possible that TFP simply induced more negative effects in patients than SFT.
A small (N = 34), randomized controlled trial assessed brief cognitive therapy, linked to a manual and incorporating elements of dialectical behaviour therapy, in the treatment of recurrent self-harm in people with cluster B personality difficulties and disorders.(30)
Manual-assisted cognitive treatment (MACT) is a complex sixsession treatment based on the theory that deliberate self-harm and suicide attempts stem from distorted cognitive schemas and coping skills deficits.(31) It incorporates elements of bibliotherapy, CBT, and DBT, as well as psychoeducation in relation to self-harm and suicide attempts, and a functional analysis of specific episodes. The treatment also involves strategies to regulate emotion, such as distraction, crisis planning, and problem-solving strategies. Cognitive restructuring strategies and management of negative thinking are incorporated in the second phase of the programme, which includes components for the management of substance abuse and relapse prevention. Its brevity makes MACT a potentially valuable intervention from a public health standpoint. In a clinical trial, 34 self-harm repeaters with a parasuicide attempt in the preceding 12 months were randomly allocated to MACT or treatment as usual (TAU). The rate of suicide acts was lower with MACT, and self-rated depressive symptoms also improved. The mean treatment time was 2.7 sessions, and the average cost of care was 46 per cent less with MACT. A subsequent larger study (N = 480) did not find evidence that time to repeat parasuicide was extended following MACT, although there was a decrease in the cost of care.(32) A randomized controlled trial with 104 people with borderline personality disorder with a longer period of treatment (up to 30 sessions) found significant benefit with regard to suicidal behaviour but a nonsignificant increase in emergency presentations in the cognitive behaviour therapy group.(33) The CBT arm used less resources, although no significant cost-effectiveness advantage was demonstrated. Those who received CBT showed less evidence of dysfunctional beliefs, lower state anxiety scores, and less positive symptom distress.
Systems training for emotional predictability and problem solving (STEPPS)(34) is a group treatment offered as an adjunct to other treatments rather than as a sole intervention. It is a 20-week manualized programme of psychoeducation and behavioural management focusing on maladaptive schemas and including both professional and family carers. Subjects are encouraged to continue their usual care, including individual psychotherapy, medication, and case management, and are required to designate a mental health professional who would provide ongoing care and could be reached in a crisis. Data from 52 patients suggests some reduction in impulsive and suicidal behaviour and some improvement on measures of depression, but no follow-up data is yet available. An RCT is currently ongoing. In Holland, a retrospective assessment of the experience of 85 patients enrolled in STEPPS groups(35) reported significant improvement on all subscales of the SCL-90, particularly those assessing anxiety, depression, and interpersonal sensitivity. Patients and therapists reported moderate to high levels of acceptance for the treatment in both studies. As most of the effective programmes for BPD are long-term and expensive, a short-term efficacious treatment will be of great value. However, even if found to be effective in a clinical trial, its effectiveness will depend on the nature of the treatment as usual.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


